While this AP has not been perfect through the weekend, it has shown the ability to learn and improve on dual hormone therapy. I am INCREDIBLY encouraged and EXCITED beyond belief at the thought of being able to wear the 1st generation commercially available AP as soon as possible.
Average BG, Saturday – 142
Average BG, Sunday – 126
And I didn’t do a thing. Now that’s just cool.
There will be naysayers, and I’m ok with that. Different insulin pumps are liked or disliked for different reasons. CGM’s are utilized by different folks. What I am saying here is that you combine these devices and make T1D management easier? I am in.
The hurdles faced during the weekend are being addressed with the next generation AP. The research director is already planning for the generation after that and working towards the successful delivery of a dependable product.
I am encouraged by this team because they have a personal drive. Ed Damiano’s son is T1D and Ed wants this device before his son goes to college in 5 years. He knows the hurdles, but is not frustrated by them, and the culture of the study staff follows suit. I am impressed and look forward to working with them again.
I want to thank the study staff, especially Kathy, Kathy, Kendra (all pictured L-R), Rick, Helen Ann,and of course the lead guys Ed Damiano and Firas El-Khatib.